Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Evolent Health, Inc. Director's Dealing 2021

Jun 14, 2021

32214_dirs_2021-06-14_b27c0f8d-9e51-4280-9e78-eda77524cfc4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Evolent Health, Inc. (EVH)
CIK: 0001628908
Period of Report: 2021-06-10

Reporting Person: KECK KIM (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-06-10 Class A Common Stock A 7785 Acquired 10660 Direct

Footnotes

F1: Represents restricted stock units granted to Ms. Keck pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.

F2: Securities vest on the earlier of June 10, 2022 and the date of the company's 2022 annual meeting, subject to the reporting person's continued service on the vesting date.